نتائج البحث - "Muscarinic antagonist"

1

Beyond Dual Bronchodilation – Triple Therapy, When and Why

المؤلفون: Cazzola, Mario, Rogliani, Paola, Laitano, Rossella, Calzetta, Luigino, Matera, Maria Gabriella

المساهمون: Cazzola, M., Rogliani, P., Laitano, R., Calzetta, L., Matera, M. G.

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beb3fddf8a5c59fd837dc8389b56f60cTest
https://doi.org/10.2147/copd.s345263Test

2

When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment

المؤلفون: Wen-Chien Cheng, Wu-Huei Hsu, Chih-Yu Chen, Biing-Ru Wu, Wei Chun Chen, Chia-Hung Chen, Chih Yen Tu, Te Chun Hsia, Wei-Chih Liao

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: long-acting β2 agonist, medicine.medical_specialty, Multivariate analysis, medicine.drug_class, LABA, Muscarinic Antagonists, Disease, International Journal of Chronic Obstructive Pulmonary Disease, inhaled corticosteroid, CID, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, 0302 clinical medicine, Adrenal Cortex Hormones, Internal medicine, Administration, Inhalation, long-acting muscarinic antagonist, COPD, Humans, Medicine, 030212 general & internal medicine, chronic pulmonary obstructive disease, Adrenergic beta-2 Receptor Agonists, Original Research, clinically important deterioration, Retrospective Studies, biology, Receiver operating characteristic, business.industry, LAMA, Muscarinic antagonist, General Medicine, Lama, biology.organism_classification, medicine.disease, Bronchodilator Agents, 030228 respiratory system, ICS, triple therapy, Ics laba, Disease Progression, Corticosteroid, Drug Therapy, Combination, business, medicine.drug

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40d1c3a1c43ae6a1bb67ff4d5df786a6Test
https://doi.org/10.2147/copd.s279482Test

3

Medium-dose ICS-containing FDCs reduce all-cause mortality in COPD patients: an in-depth analysis of dual and triple therapies

المؤلفون: Luigino Calzetta, Maria Gabriella Matera, Paola Rogliani, Beatrice Ludovica Ritondo, Alfredo Chetta

المساهمون: Calzetta, L., Ritondo, B. L., Matera, M. G., Chetta, A., Rogliani, P.

المصدر: Expert Review of Respiratory Medicine. 16:357-365

مصطلحات موضوعية: Adrenergic beta-2 Receptor Agonist, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Copd patients, LABA, Muscarinic Antagonists, Pulmonary Disease, Chronic Obstructive, Administration, Inhalation, Settore MED/10, medicine, COPD, Humans, Immunology and Allergy, Intensive care medicine, network meta-analysis, Adrenergic beta-2 Receptor Agonists, Bronchodilator Agent, biology, business.industry, Nebulizers and Vaporizers, LAMA, Public Health, Environmental and Occupational Health, DUAL (cognitive architecture), Lama, biology.organism_classification, medicine.disease, mortality, Bronchodilator Agents, network meta-analysi, Muscarinic Antagonist, ICS, triple therapy, Vital Status, business, Nebulizers and Vaporizer, hormones, hormone substitutes, and hormone antagonists, All cause mortality, Human

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aae2344cf1570e66b6b426d758d298a2Test
https://doi.org/10.1080/17476348.2021.1951237Test

4

A Real-World Analysis of Treatment Patterns and Clinical Characteristics Among Patients with COPD Who Initiated Multiple-Inhaler Triple Therapy in New Zealand

المؤلفون: Raewyn J Scott, Tim Holbrook, Brett Marett, Robert P. Young, Dominique Milea, Anthony Braganza, Barry Gribben, Xiaomeng Xu, Aldo Amador Navarro Rojas

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: medicine.medical_specialty, medicine.drug_class, long-acting β-agonist, Treatment duration, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, inhaled corticosteroid, chronic obstructive pulmonary disease, Persistence (computer science), Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, 0302 clinical medicine, Adrenal Cortex Hormones, multiple-inhaler triple therapy, Internal medicine, Bronchodilator, Administration, Inhalation, Humans, long-acting muscarinic antagonist, Medicine, 030212 general & internal medicine, Medical prescription, Adrenergic beta-2 Receptor Agonists, Aged, Retrospective Studies, Original Research, COPD, business.industry, Nebulizers and Vaporizers, Inhaler, Mean age, General Medicine, medicine.disease, Bronchodilator Agents, 030228 respiratory system, Corticosteroid, Drug Therapy, Combination, business, New Zealand

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a5fba999363668a6349da1d05c016efTest
https://doi.org/10.2147/copd.s295183Test

5

Reducing and managing chronic obstructive pulmonary disease exacerbations with tiotropium + olodaterol

المؤلفون: Sean Duffy, Gerard J. Criner

المصدر: Current Medical Research and Opinion. 37:275-284

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dec7994b368dd20d12a3f250d924f7fcTest
https://doi.org/10.1080/03007995.2020.1841615Test

6

Patient Characteristics and Healthcare Resource Utilization Among Patients with COPD New to LAMA/LABA Fixed-Dose Combination Treatment in US-Based Real-World Practice

المؤلفون: Deniz Guranlioglu, Bo Ding, Dan O'Brien, Lee Kallenbach, Lukas Slipski, Alan Wilk

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: β2-agonist, Male, medicine.medical_specialty, muscarinic antagonist, Fixed-dose combination, Pharmacy, disease characteristics, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, demographic characteristics, Pulmonary Disease, Chronic Obstructive, Maintenance therapy, Adrenal Cortex Hormones, Internal medicine, cost, Administration, Inhalation, medicine, Humans, Medical prescription, Adrenergic beta-2 Receptor Agonists, Original Research, Aged, Retrospective Studies, COPD, biology, business.industry, General Medicine, Lama, medicine.disease, biology.organism_classification, Bronchodilator Agents, Treatment Outcome, Female, Observational study, business, Delivery of Health Care, Cohort study

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dadaa4796e26d18651c9f4b1173e64dTest
https://doi.org/10.2147/copd.s238408Test

7

Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies

المؤلفون: Colin Reisner, Klaus F. Rabe, Martin Jenkins, Brian Lipworth, Ubaldo J. Martin, Fernando J. Martinez, Samir Arora

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Male, Time Factors, Exacerbation, bronchodilator, muscarinic antagonist, Severity of Illness Index, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Forced Expiratory Volume, Formoterol Fumarate, Bronchodilator, β2- agonist, Multicenter Studies as Topic, 030212 general & internal medicine, Lung, Original Research, Randomized Controlled Trials as Topic, education.field_of_study, COPD, integumentary system, co-suspension delivery technology, General Medicine, Middle Aged, Metered-dose inhaler, Obstructive lung disease, Bronchodilator Agents, Drug Combinations, Treatment Outcome, Female, medicine.medical_specialty, medicine.drug_class, Population, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, Placebo, 03 medical and health sciences, Internal medicine, Administration, Inhalation, medicine, Humans, Metered Dose Inhalers, education, Adrenergic beta-2 Receptor Agonists, Aged, business.industry, lung function, Recovery of Function, medicine.disease, Glycopyrrolate, Clinical Trials, Phase III as Topic, 030228 respiratory system, business

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::168165fcd6c39542bd6a0b409b60d3ecTest
https://doi.org/10.2147/copd.s229794Test

8

Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD

المؤلفون: Anthony D'Urzo, Russell Wiseman, Peter Kardos

المساهمون: Russell, Richard

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: safety, medicine.medical_specialty, Time Factors, Exacerbation, Health Status, Clinical Decision-Making, efficacy, Muscarinic Antagonists, Review, Drug Prescriptions, Drug Administration Schedule, inhaler, Medication Adherence, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Forced Expiratory Volume, medicine, Humans, COPD, long-acting muscarinic antagonist, In patient, ddc:610, adherence, 030212 general & internal medicine, Intensive care medicine, Lung, Lung function, Randomized Controlled Trials as Topic, Weight of evidence, business.industry, Inhaler, Muscarinic antagonist, Patient Preference, Recovery of Function, General Medicine, medicine.disease, Bronchodilator Agents, respiratory tract diseases, Treatment Outcome, Long acting, 030228 respiratory system, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afb9f1ed4cc31011e61003c00463594cTest
https://doi.org/10.2147/copd.s160577Test

9

Characteristics of 2017 GOLD COPD group A: a multicenter cross-sectional CAP study in Japan

المؤلفون: Sho Uehara, Maki Asami-Noyama, Keiji Oishi, Nobutaka Edakuni, Tsunahiko Hirano, Kazuto Matsunaga, Kazuki Hamada, Yoshikazu Yamaji, Ryo Suetake, Kosuke Ito

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Male, Databases, Factual, Exacerbation, Copd patients, Vital Capacity, Severity of Illness Index, Group A, Pulmonary function testing, Pulmonary Disease, Chronic Obstructive, exacerbation, 0302 clinical medicine, Japan, Adrenal Cortex Hormones, Risk Factors, Forced Expiratory Volume, 030212 general & internal medicine, Lung, Original Research, Aged, 80 and over, COPD, Age Factors, General Medicine, Middle Aged, Prognosis, Bronchodilator Agents, Disease Progression, Drug Therapy, Combination, Female, mMRC, medicine.drug, Adult, medicine.medical_specialty, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, Risk Assessment, Secondary care, 03 medical and health sciences, Pharmacotherapy, Predictive Value of Tests, Internal medicine, medicine, Humans, GOLD, Adrenergic beta-2 Receptor Agonists, Aged, business.industry, Muscarinic antagonist, medicine.disease, Cross-Sectional Studies, 030228 respiratory system, business

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1c9be399ba9a6a4670ff4c581ae5a32Test
https://doi.org/10.2147/copd.s181938Test

10

Current appraisal of single inhaler triple therapy in COPD

المؤلفون: Brian Lipworth, Sunny Jabbal, Chris RuiWen Kuo

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Male, Budesonide, Exacerbation, Severity of Illness Index, Pulmonary Disease, Chronic Obstructive, exacerbation, 0302 clinical medicine, Adrenal Cortex Hormones, 030212 general & internal medicine, Randomized Controlled Trials as Topic, COPD, biology, General Medicine, Middle Aged, Lama, Bronchodilator Agents, Treatment Outcome, Editorial, Drug Therapy, Combination, Female, hormones, hormone substitutes, and hormone antagonists, medicine.drug, Adult, medicine.medical_specialty, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, Risk Assessment, inhaled corticosteroid, Fluticasone propionate, 03 medical and health sciences, Internal medicine, Administration, Inhalation, medicine, Humans, long-acting muscarinic antagonist, Adrenergic beta-2 Receptor Agonists, Aged, business.industry, Nebulizers and Vaporizers, Inhaler, lung function, Beclometasone dipropionate, medicine.disease, biology.organism_classification, long-acting beta-agonist, Pneumonia, 030228 respiratory system, business, Follow-Up Studies

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efb0d2094d070775f94fa9e489688615Test
https://doi.org/10.2147/copd.s177333Test

تنقيح النتائج